CORTNEY LANGERHOLC: Open Payments
NPI 1386260396 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$925 in 52 payments from 18 companies in 2025. Trend: 2023 $1,510 · 2024 $1,452 · 2025 $925
Food & beverage: $925
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $237 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $212 |
| Lilly USA, LLC | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $60 |
| Novo Nordisk Inc | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Exact Sciences Corporation | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Stryker Corporation | 1 | $30 |
Products named: CAPLYTA, VRAYLAR, XIFAXAN, UBRELVY, MOUNJARO, AIRSUPRA, The Cologuard Plus Collection Kit, LEQVIO.
Industry payments across PA — which companies pay providers there.
